- 2022
-
- 10
Attended Biosimilar Event BioEurope, BioJapan, & CPHI
- 10
Biosimilar (RBS-001) Clinical Studies (Phase 3)
- 5
Biosimilar (RBS-001) Preclinical Studies Contract
- 10
- 2021
-
- 04
Eylea biosimilar clinical production and provisional out-licensing contract
- 03
Eylea biosimilar cell bank established
- 02
Government grant project for Eylea biosimilar development
- 04
- 2020
-
- 05
KIPO project: IP Narae Support
- 05
KIPO project: Road Day of Intellectual Property Start-up
- 05
KIPO project: Support of Innovation patent Start-up company
- 05
KITIA project: Support of Investment Attraction
- 05
- 2019
-
- 09
Chungbuk-do project: Creation Value of High-tech Medical technology
- 08
KIPO project: IP Narae Support
- 06
CBNU project: LINC+ Technology Development of Industry-University
- 02
MOTIE project: R&D Support of The Industry-University Fusion Center
- 09
- 2018
-
- 11
Headquarters move to Cheongju Science Business Plaza
- 05
Inno-Biz Class A Small Enterprise Innovative Technologies accreditation
- 11
- 2017
-
- 12
LMO Class 1 Laboratory accreditation
- 12
- 2016
-
- 04
CEO Visit to government agencies in the Nanjing, Yangzhou, and Ningbo cities of China with plans to establish a joint venture company
- 01
Osong Medical Innovation Foundation: Creation Value for Promotion of R&D Grant selection
- 01
Osong Medical Innovation Foundation: Creation Value for Product and Process Development of Clinical Specimens Grant selection
- 04
- 2015
-
- 12
KASBP-DC’s 2015 US Cooperative Conference for Life Science Industry (KUCCLSI) participant
- 11
Ministry of Trade, Industry and Energy: Promotion of Province non-R&D Grant selection
- 10
2015 BioEurope (Munich, Germany) exhibitioner
- 10
Korea Institute of Startup and Entrepreneurship Development: Establishment Business Customization Grant selection
- 08
Ministry of Trade, Industry, and Energy: Global Technology Consulting Grant selection
- 08
Chungbuk Industry University Cooperation Institute: R&D Grant selection
- 06
Small and Medium Business Administration: Establishment of Business Growth Grant selection
- 06
Chinese Biopharmaceutical Association 2016 Annual Conference (Lianyungang, China) participant
- 05
Ministry of Trade, Industry and Energy: Focus on Fostering Regional Business R&D Grant selection
- 04
2015 BioKorea (Seoul, Korea) exhibitioner
- 04
Venture Business certification by the Korea Venture Capital Association
- 03
R&D institute establishment and KOITA accreditation
- 12